How much dividend does Aptinyx pay?
Over the past 12 months, Aptinyx paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Aptinyx is expected to pay a dividend of 0 USD.
Aptinyx Dividend 2024
Aptinyx Dividend
0 USD
Aptinyx Dividend yield
Ticker
APTX
ISIN
US03836N1037
WKN
A2JPB1
How much dividend does Aptinyx 2024 pay?
According to the latest status from September 2024, Aptinyx paid a total of 0 USD per share in dividends within the last 12 months. With the current Aptinyx price of 0.1 USD, this corresponds to a dividend yield of 0 %. A dividend is paid times per year.
| = |
Historical Aptinyx Dividends
A dividend is paid times per year. Last year, the payout months were and .
| Paydate | Dividend |
|---|---|
| 2/2/2024 | 0.1 |
1
Aptinyx dividend history and estimates US03836N1037 · A2JPB1
In 2023, Aptinyx paid a dividend amounting to 0 USD. Dividend means that Aptinyx distributes a portion of its profits to its owners.
3 years
5 years
10 years
25 Years
Max
Dividend
Dividend (Estimate)
Details
Dividend
ⓘDividend Overview
The dividend per year chart for Aptinyx provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.
Interpretation and Use
A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Aptinyx’s potential for long-term investment and income generation through dividends.
Investment Strategy
Incorporate the dividend data in evaluating Aptinyx's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.
Aptinyx Dividend History
| Date | Aptinyx Dividend |
|---|
| Dividend | Dividend (Estimate) | |
|---|---|---|
| 2016 | 0 USD | 0 USD |
| 2017 | 0 USD | 0 USD |
| 2018 | 0 USD | 0 USD |
| 2019 | 0 USD | 0 USD |
| 2020 | 0 USD | 0 USD |
| 2021 | 0 USD | 0 USD |
| 2022 | 0 USD | 0 USD |
| 2023e | 0 USD | 0 USD |
| 2024e | 0 USD | 0 USD |
| 2025e | 0 USD | 0 USD |
| 2026e | 0 USD | 0 USD |
| 2027e | 0 USD | 0 USD |
| 2028e | 0 USD | 0 USD |
Is the Aptinyx Dividend Safe?
Aptinyx has been increasing the dividend for 1 years.
Over the past 7 years, Aptinyx has increased it by an annual 0 %.
Over a five-year period, the distribution increased by 0%.
Analysts expect a Dividend Cut of -100% for the current fiscal year.
Dividend Details
Understanding Aptinyx's Dividend Distributions
Aptinyx’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.
Year-to-Year Comparison
Examining Aptinyx's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.
Impact on Investments
Aptinyx's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.
Interpreting Dividend Fluctuations
Changes in Aptinyx’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.
Aptinyx Aktienanalyse
What does Aptinyx do?
Aptinyx Inc is a biopharmaceutical company specializing in the development of therapies for the treatment of neurological diseases. The company was founded in 2015 in Evanston, Illinois, USA, and has since achieved an impressive track record in researching and developing innovative therapies. The history of Aptinyx Inc begins with a group of experienced scientists and researchers who came together to push the boundaries of neuroscience research and discover new treatment options for people with brain disorders. The company is based on the belief that the human brain is a fascinating and complex entity that still holds many secrets. The company is committed to improving human well-being through innovative neurotherapeutic products and services. Aptinyx Inc's business model focuses on the research, development, and commercialization of novel therapeutic treatments for neurological diseases. The company closely collaborates with leading academic institutions and facilities to leverage the best research findings and methods. The company has a strong scientific foundation led by an experienced team of researchers and developers working on innovative biomarker and therapy strategies. Aptinyx Inc has focused on the development of neuromodulators and neuroprotectants to treat neurological diseases, including pain disorders, peripheral neuropathies, neuropathic pain, Parkinson's disease, post-traumatic stress disorder (PTSD), and other central nervous system disorders. Aptinyx Inc's products are based on a comprehensive understanding of the fundamentals of the nervous system and how it functions. The company offers a variety of products and services, including novel therapeutics for the treatment of pain, neuropathy, and other neurological diseases. These products are based on the utilization of Aptinyx's proprietary technologies to selectively modulate specific cell types and signaling pathways in the nervous system. The products and services of Aptinyx Inc have been regulated by leading health authorities in the US and Europe. Aptinyx Inc has two main divisions of products: the first focus is on the development of neuromodulators that specifically alleviate pain and modulate the brain. The second focus is on the development of neuroprotectants that help protect neurons and reduce inflammation in the nervous system. These two divisions are closely interconnected as they are based on a common platform grounded in the exploration of novel biomarkers and therapeutic targets. The products of Aptinyx Inc are designed for both pain relief and improvement of neural functions. Additionally, these products aim to enhance patient experience and quality of life. The company consistently collaborates with potential partners and experts to develop products tailored to the needs of patients and healthcare providers. Overall, Aptinyx Inc has revolutionized the world of neuroscience by exploring and developing innovative solutions for neurological diseases. The company has achieved an impressive track record by utilizing its scientific expertise and groundbreaking technologies to set new trends in neuroscience research and therapeutics. In summary, Aptinyx Inc has developed a unique approach to the development of neuromodulators and neuroprotectants based on a deep understanding of the structure and function of the nervous system. The products and services of the company have the potential to play a significant role in improving the quality of life for patients with neurological diseases. Aptinyx is one of the most popular companies on Eulerpool.com.Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Frequently Asked Questions about Aptinyx stock
What is the dividend yield of Aptinyx?
The current dividend yield of Aptinyx is .
When does Aptinyx pay dividends?
Aptinyx pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Aptinyx?
Aptinyx paid dividends every year for the past 0 years.
What is the dividend of Aptinyx?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Aptinyx located?
Aptinyx is assigned to the 'Health' sector.
Wann musste ich die Aktien von Aptinyx kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Aptinyx from 12/29/2023 amounting to 0.099 USD, you needed to have the stock in your portfolio before the ex-date on 1/2/2024.
When did Aptinyx pay the last dividend?
The last dividend was paid out on 12/29/2023.
What was the dividend of Aptinyx in the year 2023?
In the year 2023, Aptinyx distributed 0 USD as dividends.
In which currency does Aptinyx pay out the dividend?
The dividends of Aptinyx are distributed in USD.
Andere Kennzahlen von Aptinyx
Our stock analysis for Aptinyx Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Aptinyx Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
